Mutations on GRIN genes, encoding for the N-methyl-D-Aspartate receptor (NMDAR) subunits, have been recently associated with autosomic dominant paediatric encephalopathies, a rare severe condition with intellectual disability, hypotonia, communication deficits and motor impairment. Along the last years, we have generated a GRINpathy toolbox (structural model, genotype-phenotype relationship, experimental pipeline) allowing functional GRIN variants pathogenicity assessment and evaluation of personalised therapeutic strategies, including a clinical proof-of-concept study. Nevertheless, there is an urgent need to accelerate GRIN variants annotation, by means of automatisation and development of a predictive algorithm, as well as developing GRINpathy animal models to both elucidate GRIN-related disorders pathophysiology and to evaluate personalised therapies. Our multicentric translational initiative GRINcure aims to provide a comprehensive scenario of GRINpathies, through the development of a four pillars structure: i) RareCommons-GRIN database, an interactive web-based GRIN patients registry, ii) MetaGRIN: predictive algorithm integrating genetic, structural, functional and clinical data associated with GRIN variants, iii) PhenoGRIN, generation and phenotypation of GRINpathy models in zebrafish, iv) PharmaGRIN, cell-based and in vivo screening of GRINpathies personalised medicine. GRINcure initiative is a unique platform composed by an existing team integrating basic, clinical research and biotechnological industry, with the support of European GRIN families and clinicans. In summary, GRINcure will contribute to define GRINpathies pathophysiology and to evaluate personalised pharmacotherapies, while consolidating our team at the forefront of European GRIN-related disorders research and precision medicine.
Encefalopatía pediátrica
medicina personalizada
receptores NMDA
neurotransmisión glutamatérgica
trastornos del neurodesarrollo
Acción Estratégica en Salud (AES)
01/01/2020 - 31/12/2022
ALTAFAJ TARDIO, XAVIER
INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
CATALUÑA
BARCELONA
123,420 €